Key clinical point: Non-Hispanic black patients with acne may be at risk for undertreatment, compared with non-Hispanic white patients with acne.
Major finding: Non-Hispanic black patients with acne were significantly more likely to be prescribed topical retinoids (odds ratio, 1.25) and topical antibiotics (OR, 1.35), compared with their white counterparts.
Study details: Retrospective, cohort study of deidentified data 29,928 adults treated for acne.
Disclosures: The study was supported in part by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health, and by a Pfizer Fellowship in Dermatology Patient Oriented Research grant to the trustees of the University of Pennsylvania. Dr. Barbieri had no financial conflicts to disclose. One of the study coauthors disclosed relationships with Pfizer, Eli Lilly, and Novartis.
Barbieri JS et al. JAMA Dermatol. 2020 Feb 5. doi: 10.1001/jamadermatol.2019.4818.